Literature DB >> 33430341

Systemic Mastocytosis Associated with "Smoldering" Multiple Myeloma.

Magda Zanelli1, Stefano Ricci1, Maurizio Zizzo2,3, Francesca Sanguedolce4, Federica De Giorgi1,5, Andrea Palicelli1, Giovanni Martino6, Stefano Ascani6,7.   

Abstract

A 79-year-old woman presented with a long history of peripheral eosinophilia. Previous right hemicolectomy for colonic polyposis was reported. Laboratory tests were notable for mild macrocitic anaemia and eosinophilia. β2 microglobulin and serum tryptase levels were elevated. Serum immunofixation revealed IgA/kappa monoclonal protein. Bence-Jones protein was positive. Bone marrow (BM) biopsy revealed the coexistence of two neoplastic components. Cohesive clusters of bland-looking, spindle-shaped mast cells, representing 20% of marrow cellularity, were close to aggregates of mature plasma cells occupying 40% of marrow cellularity. Molecular analysis on marrow aspirate demonstrated KIT D816V mutation, TET2 mutation, monoallelic deletion of TP53/17p13 and trisomy of ATM/11q23. A bone density study revealed mild osteoporosis. Full skeletal X-rays and magnetic resonance imaging (MRI) of spine and hips showed multiple, small rarefaction areas and an old L1-L2 fracture, both ascribed to osteoporosis. The association of systemic mastocytosis (SM) and multiple myeloma (MM) is very uncommon. The coexistence of SM with MM placed our patient in the SM with associated clonal haematological non-mast-cell lineage disease (SM-AHN) subtype. Midostaurin therapy was started.

Entities:  

Keywords:  bone marrow; mastocytosis; myeloma

Year:  2021        PMID: 33430341      PMCID: PMC7825792          DOI: 10.3390/diagnostics11010088

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  5 in total

1.  Systemic mastocytosis in association with plasma cell dyscrasias: report of a case and review of the literature.

Authors:  Pooja Motwani; Mehmet Kocoglu; Robert B Lorsbach
Journal:  Leuk Res       Date:  2009-01-14       Impact factor: 3.156

2.  Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management.

Authors:  Animesh Pardanani
Journal:  Am J Hematol       Date:  2019-01-02       Impact factor: 10.047

3.  Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.

Authors:  R Bataille; M Jourdan; X G Zhang; B Klein
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

4.  A case of bone marrow mastocytosis associated with multiple myeloma.

Authors:  W Hagen; J Schwarzmeier; S Walchshofer; N Zojer; A Chott; C Sillaber; J Ackermann; I Simonitsch; H J Bühring; J Drach; K Lechner; H P Horny; P Valent
Journal:  Ann Hematol       Date:  1998 Mar-Apr       Impact factor: 3.673

5.  International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study.

Authors:  Wolfgang R Sperr; Michael Kundi; Ivan Alvarez-Twose; Bjorn van Anrooij; Joanna N G Oude Elberink; Aleksandra Gorska; Marek Niedoszytko; Karoline V Gleixner; Emir Hadzijusufovic; Roberta Zanotti; Patrizia Bonadonna; Massimiliano Bonifacio; Cecelia Perkins; Anja Illerhaus; Chiara Elena; Serena Merante; Khalid Shoumariyeh; Nikolas von Bubnoff; Roberta Parente; Mohamad Jawhar; Anna Belloni Fortina; Francesca Caroppo; Knut Brockow; Alexander Zink; David Fuchs; Alex J Kilbertus; Akif Selim Yavuz; Michael Doubek; Hans Hägglund; Jens Panse; Vito Sabato; Agnes Bretterklieber; Dietger Niederwieser; Christine Breynaert; Karin Hartmann; Massimo Triggiani; Boguslaw Nedoszytko; Andreas Reiter; Alberto Orfao; Olivier Hermine; Jason Gotlib; Michel Arock; Hanneke C Kluin-Nelemans; Peter Valent
Journal:  Lancet Haematol       Date:  2019-10-31       Impact factor: 18.959

  5 in total
  7 in total

1.  What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models).

Authors:  Andrea Palicelli; Stefania Croci; Alessandra Bisagni; Eleonora Zanetti; Dario De Biase; Beatrice Melli; Francesca Sanguedolce; Moira Ragazzi; Magda Zanelli; Alcides Chaux; Sofia Cañete-Portillo; Maria Paola Bonasoni; Alessandra Soriano; Stefano Ascani; Maurizio Zizzo; Carolina Castro Ruiz; Antonio De Leo; Guido Giordano; Matteo Landriscina; Giuseppe Carrieri; Luigi Cormio; Daniel M Berney; Jatin Gandhi; Giacomo Santandrea; Martina Bonacini
Journal:  Int J Mol Sci       Date:  2021-11-14       Impact factor: 5.923

2.  What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 2: Clinic-Pathologic Correlations.

Authors:  Andrea Palicelli; Martina Bonacini; Stefania Croci; Cristina Magi-Galluzzi; Sofia Cañete-Portillo; Alcides Chaux; Alessandra Bisagni; Eleonora Zanetti; Dario De Biase; Beatrice Melli; Francesca Sanguedolce; Magda Zanelli; Maria Paola Bonasoni; Loredana De Marco; Alessandra Soriano; Stefano Ascani; Maurizio Zizzo; Carolina Castro Ruiz; Antonio De Leo; Guido Giordano; Matteo Landriscina; Giuseppe Carrieri; Luigi Cormio; Daniel M Berney; Jatin Gandhi; Giacomo Santandrea; Maria Carolina Gelli; Alessandro Tafuni; Moira Ragazzi
Journal:  Cells       Date:  2021-11-14       Impact factor: 6.600

3.  What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment.

Authors:  Andrea Palicelli; Stefania Croci; Alessandra Bisagni; Eleonora Zanetti; Dario De Biase; Beatrice Melli; Francesca Sanguedolce; Moira Ragazzi; Magda Zanelli; Alcides Chaux; Sofia Cañete-Portillo; Maria Paola Bonasoni; Alessandra Soriano; Stefano Ascani; Maurizio Zizzo; Carolina Castro Ruiz; Antonio De Leo; Guido Giordano; Matteo Landriscina; Giuseppe Carrieri; Luigi Cormio; Daniel M Berney; Jatin Gandhi; Valerio Copelli; Giuditta Bernardelli; Giacomo Santandrea; Martina Bonacini
Journal:  Int J Mol Sci       Date:  2021-11-15       Impact factor: 5.923

Review 4.  What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, BRCA, PTEN, and Other Genes.

Authors:  Andrea Palicelli; Stefania Croci; Alessandra Bisagni; Eleonora Zanetti; Dario De Biase; Beatrice Melli; Francesca Sanguedolce; Moira Ragazzi; Magda Zanelli; Alcides Chaux; Sofia Cañete-Portillo; Maria Paola Bonasoni; Stefano Ascani; Antonio De Leo; Guido Giordano; Matteo Landriscina; Giuseppe Carrieri; Luigi Cormio; Jatin Gandhi; Davide Nicoli; Enrico Farnetti; Simonetta Piana; Alessandro Tafuni; Martina Bonacini
Journal:  Biomedicines       Date:  2022-01-22

5.  What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1.

Authors:  Andrea Palicelli; Stefania Croci; Alessandra Bisagni; Eleonora Zanetti; Dario De Biase; Beatrice Melli; Francesca Sanguedolce; Moira Ragazzi; Magda Zanelli; Alcides Chaux; Sofia Cañete-Portillo; Maria Paola Bonasoni; Alessandra Soriano; Stefano Ascani; Maurizio Zizzo; Carolina Castro Ruiz; Antonio De Leo; Guido Giordano; Matteo Landriscina; Giuseppe Carrieri; Luigi Cormio; Daniel M Berney; Jatin Gandhi; Davide Nicoli; Enrico Farnetti; Giacomo Santandrea; Martina Bonacini
Journal:  Int J Mol Sci       Date:  2021-11-15       Impact factor: 5.923

6.  What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation Variables.

Authors:  Andrea Palicelli; Martina Bonacini; Stefania Croci; Cristina Magi-Galluzzi; Sofia Cañete-Portillo; Alcides Chaux; Alessandra Bisagni; Eleonora Zanetti; Dario De Biase; Beatrice Melli; Francesca Sanguedolce; Moira Ragazzi; Maria Paola Bonasoni; Alessandra Soriano; Stefano Ascani; Maurizio Zizzo; Carolina Castro Ruiz; Antonio De Leo; Guido Giordano; Matteo Landriscina; Giuseppe Carrieri; Luigi Cormio; Daniel M Berney; Daniel Athanazio; Jatin Gandhi; Alberto Cavazza; Giacomo Santandrea; Alessandro Tafuni; Magda Zanelli
Journal:  Cells       Date:  2021-11-14       Impact factor: 6.600

Review 7.  What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 7: PD-L1 Expression in Liquid Biopsy.

Authors:  Andrea Palicelli; Martina Bonacini; Stefania Croci; Alessandra Bisagni; Eleonora Zanetti; Dario De Biase; Francesca Sanguedolce; Moira Ragazzi; Magda Zanelli; Alcides Chaux; Sofia Cañete-Portillo; Maria Paola Bonasoni; Stefano Ascani; Antonio De Leo; Jatin Gandhi; Alessandro Tafuni; Beatrice Melli
Journal:  J Pers Med       Date:  2021-12-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.